For Researchers and Companies
iPS Cell Stock Project
Stocking iPS cells for regenerative medicine to save time and cost.
HLA-homozygous iPS cells
iPS cells generated from donors with HLA homozygous in their expression for HLA-A, HLA-B, or HLA-DR
Learn moreHLA-genome-edited iPS cells
Plans to manufacture and provide HLA-A, -B, and -CIITA knockout iPS cells by genome editing the iPS cell stock produced from HLA-homozygous donors.
Learn moremy iPS Project
Developing technologies to manufacture iPS cells generated from patients' own cells at reasonable cost. This approach has less risk of immune rejection.
Research Materials
(Bioresources)
Provision of iPS cells made from COVID-19
convalescent patients
Learn more
Our Services
A list of our services.
If you have any questions, please feel free to contact us.
Education and Support
Collaboration
To push forward the medical application of iPS cells (my iPS, regenerative medicine, drug discovery, etc.), we seek partners for research collaborations.
